sbynews

DelMarVa’s Premier Source for Conservative News, Opinion, Analysis, and Human Interest

Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349

The opinions expressed by columnists are their own and do not represent our advertisers

Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To ‘Horse Paste’

Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that it’s launching an accelerated Phase 2/3 trial for a COVID prophylactic pill designed to ward off COVID in those may have come in contact with the disease.

Coincidentally (or not), Pfizer’s drug shares at least one mechanism of action as Ivermectin – an anti-parasitic used in humans for decades, which functions as a protease inhibitor against Covid-19, which researchers speculate “could be the biophysical basis behind its antiviral efficiency.”

Lo and behold, Pfizer’s new drug – which some have jokingly dubbed “Pfizermectin,” is described by the pharmaceutical giant as a “potent protease inhibitor.”

More

2 thoughts on “Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To ‘Horse Paste’”

  1. The suppression of ivermectin and HCQ costs hundreds of thousands of lives directly from the virus and many more hundreds of thousands from the effects of the insane lockdowns.

    They have blood on their hands.

Leave a Comment

Your email address will not be published. Required fields are marked *